Sunscreen Rule Will Cost Four Times What FDA Predicted, Industry Tells OMB
This article was originally published in The Rose Sheet
Executive Summary
FDA's low-ball estimate of costs its final OTC sunscreen monograph will impose on industry - a quarter of the amount anticipated by manufacturers - relieved the agency from having to submit a full account of its rulemaking to the Office of Management and Budget, Energizer Holdings suggests
You may also be interested in...
In Brief
Council On Timing Of Sunscreen Rule
In Brief
Council On Timing Of Sunscreen Rule
J&J Contests FDA-Proposed Cap With Study Championing High SPF Sunscreens
Johnson & Johnson is strengthening its stance against FDA's proposed maximum for sun protection factors on sunscreen products with a new study refuting the notion that high SPF formulas cannot be accurately and consistently measured.